Ongoing studies

COVID-19 Phase I/II Vaccine Study

Today the MHRA concluded its review of these very rare and unusual blood clots in adults, and did not recommend any age restriction on the use of the vaccine. (MHRA Statement)

The Joint Committee on Vaccination and Immunisation, who provide scientific advice to the Department of Health, has suggested that on a precautionary basis, adults under 30 who are still unvaccinated should be offered an alternative Covid-19 vaccine, if available. (JCVI Statement)

This trial is being conducted across multiple locations in the UK.

Recruitment to this phase I/II study (COV001) is now complete. Recruitment to the phase II/III study is ongoing, and details are available here.

Ongoing studies

COVID-19 Phase I/II Vaccine Study

Bristol Area

South London and Surrey border Area

Thames Valley Area

Southampton Area

North and North-West London Area